Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 311-320 of 520 for center for individualized medicine

Edit search filters
  1. Identification of Chronic Hepatitis B Infections Among African and Asian Immigrants in Minnesota Through Community-Wide Screening

    Mankato, MN, Rochester, MN

  2. A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft

    Rochester, MN

  3. Evaluation of the Value of Exosomal DEL-1 and miRNA Levels as Biomarkers for Breast Cancer

    Jacksonville, FL

  4. Blood-Based Biomarkers in Sarcoma: A ‘Multi-Omics’ Approach

    Rochester, MN

  5. A Pilot Study to Evaluate the Molecular and Biological Phenotype of Peripheral Immune Cells in Solid Tumor Patients

    Rochester, MN

  6. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

    Rochester, MN

  7. Radicava® (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis

    Jacksonville, FL

  8. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study to Evaluate Sex and Gender in Multiple System Atrophy

    Rochester, MN

  10. Preclinical investigation of immunotherapeutic efficacy and safety of a novel oncolytic vesicular stomatitis virus expressing extracellular matrix-destructing enzymes in combination with immune checkpoint inhibitors in pancreatic adenocarcinoma

    Jacksonville, FL

.

Mayo Clinic Footer